Page last updated: 2024-08-24

2-oxothiazolidine-4-carboxylic acid and Coronary Disease

2-oxothiazolidine-4-carboxylic acid has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frei, B; Gokce, N; Holbrook, M; Keaney, JF; Leaf, C; Vita, JA1

Trials

1 trial(s) available for 2-oxothiazolidine-4-carboxylic acid and Coronary Disease

ArticleYear
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
    The Journal of clinical investigation, 1998, Mar-15, Volume: 101, Issue:6

    Topics: Administration, Oral; Aged; Arteriosclerosis; Blood Flow Velocity; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Cysteine; Double-Blind Method; Endothelium, Vascular; Female; Glutathione; Heart Rate; Humans; Hyperemia; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidation-Reduction; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Triglycerides; Ultrasonography

1998